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Although cells dying by apoptosis expose the classical ‘‘eat me’’ signal phosphatidylserine (PS),
a phagocytic transmembrane receptor for PS has proved elusive. Now cell and structural studies
(Kobayashi et al. [2007] and Santiago et al. [2007] in this issue of Immunity) implicate the type I
molecule TIM-4.Cell death and removal in the immune
system are events of profound impor-
tance, regulating immune responses
(Savill et al., 2002). Deficient clearance
of apoptotic cells may result in auto-
immunity (Hanayama et al., 2004). The
speed of apoptosis and subsequent
clearance by phagocytic cells—whether
‘‘semiprofessional’’ neighbors or ‘‘pro-
fessional’’ phagocytes such as macro-
phages and immature dendritic cells—
usually renders apoptosis histologically
inconspicuous. However, immunolo-
gists have long been aware of where
the bodies are often buried—in ‘‘tingible
body’’ macrophages in lymph nodes
and spleen. What has been less clear is
how cells dying by apoptosis are re-
cognized by immunologically important
phagocytes.
Elegant in vitro studies from Peter
Henson’s group started some 15 years
ago identified an ‘‘eat me’’ signal
apparently specific to cells dying by
apoptosis—exposure of the anionic
phospholipid phosphatidylserine (PS),
normally restricted to the inner leaflet
of the doomed cell’s plasma mem-
brane bilayer (Fadok et al., 1992).
Accumulating evidence pointed to a
L-stereospecific transmembrane PS
receptor likely expressed by particular
phagocyte populations, such as resi-
dent peritoneal macrophages, and
linked to local production of the immu-
nosuppressive cytokine TGF-b. How-
ever, the ‘‘holy grail’’ of the phagocyte
transmembrane receptor for apoptotic
cell-surface PS has proved elusive. A
type II transmembrane molecule impli-
cated by expression cloning caused
excitement (Fadok et al., 2000), espe-
cially when its deletion resulted in de-
creased clearance of apoptotic cells830 Immunity 27, December 2007 ª2007and severe lung injury (Li et al., 2003).
Nevertheless, careful analysis sug-
gested that the antibody thought to
recognize this putative receptor with
high specificity did in fact bind proteins
unlikely to mediate recognition of apo-
ptotic cells, with the unfortunate result
that the cloning and gene deletion data
are probably misleading (Bo¨se et al.,
2004).
For this reason, despite the hunger
among interested researchers for a
phagocytic transmembrane PS recep-
tor, a very recent report fromShigekazu
Nagata’s group will have been greeted
with some caution. Miyanishi et al.
(2007) raised a library of hamstermono-
clonal antibodies (mAbs)againstmouse
peritonealmacrophages.OnemAb,Kat
5-18, strongly inhibited PS-dependent
phagocytosis of apoptotic cells in vitro.
Furthermore, Kat 5-18 specifically
blocked spontaneous ingestion of apo-
ptotic cells by macrophages in the
thymus in beautiful experiments with
mice deficient in caspase-activated
DNase, in which only dying cells under-
going digestion by phagocytes exhibit
histochemically demonstrable DNA
degradation. Intriguingly, repeated in-
jections of Kat 5-18 elicited raised titers
of autoantibodies to double-stranded
DNA. Expression cloning identified
T cell immunoglobulin mucin-4 (TIM-4)
as the antigen most specifically recog-
nized by Kat 5-18. TIM family proteins,
originally identified as markers of dis-
tinct T cell subsets, are type I cell-sur-
face glycoproteins and share an immu-
noglobulinvariable (IgV)domainwithsix
cysteines, amucin-likedomain, a trans-
membrane domain, and a cytoplasmic
domain. Immunostaining pointed to
TIM-4 expression by phagocyticallyElsevier Inc.active cells in spleen, lymph nodes,
and other tissues. Furthermore, TIM-4
overexpression in fibroblasts conferred
‘‘gain of function’’ and enhanced inges-
tion of apoptotic cells. Fusion protein
experiments showed that the IgV do-
main in TIM-4, but not the mucin do-
main, specifically bound PS and not
other anionic phospholipids.
Compelling though this body of data
may appear, two reports in this issue
of Immunity provide even stronger
evidence that TIM-4 is indeed aphago-
cyte receptor for apoptotic cell PS.
Kobayashi et al. (2007) first implicated
TIM-4 by a ‘‘forward’’ rather than a
‘‘reverse’’ approach—while seeking
functional ligands for TIM family mem-
bers, they discovered that human
TIM-4 (but not TIM-2) fusion protein
bound directly to human Jurkat T cells
undergoing stimulated apoptosis.
However, the power of this observa-
tion became apparent when applying
the structural insights gained by the
second key report in this issue from
Santiago et al. (2007). The crystal
structure of the isolated N-terminal
domain of murine TIM-4 revealed a
metal ion-dependent ligand binding
site in the IgV domain, a narrow cavity
shaped by the characteristic CC0 loop
and the hydrophobic FG loop. The
structure of PS bound to the IgV
domain showed that the hydrophilic
head of the L-isomer specifically pene-
trated into this cleft, coordinating with
a metal ion captured by charged
amino acids, with the outer lips of the
cavity being composed of hydropho-
bic amino acids able to interact with
the hydrophobic fatty acid region of
PS. Crucially, alanine substitution of
any of the amino acids (119–123,
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eliminated binding to PS but also abol-
ished conferred phagocytic activity for
PS-exposing red blood cells when the
TIM-4 construct was transfected into
fibroblasts. These data seem to call
‘‘game, set, and match,’’ unequivo-
cally establishing TIM-4 as a stereo-
specific transmembrane PS receptor
capable of mediating phagocytosis of
apoptotic cells, although the cautious
may still question whether TIM-4 pro-
jects far enough from the phagocyte
plasma membrane to capture apopto-
tic cell-surface PS.
Although TIM-4 expression is quite
widespread among tissues, an impor-
tant role in the immune system could
be inferred from preferential expres-
sion in ‘‘professional’’ phagocytes
such as resident peritoneal macro-
phages and splenic dendritic cells
(Kobayashi et al., 2007). Importantly,
TIM-1, a molecule expressed in tis-
sues such as the injured kidney tubule
epithelium (where it is also known as
kidney injury molecule-1), was also
found to be a phagocytic receptor for
PS, implying that the TIM family might
also be deployed by semiprofessional,
nonmyeloid phagocytes in engulfment
of apoptotic cells, an interesting issue
requiring further research. Further-
more, whether TIM-4 and TIM-1 are
capable of stimulating TGF-b secretion
and activation needs to be a focus of
future work.
Clearly, there is a need now for a
TIM-4 loss-of-function experiment to
confirm a role in clearance of apoptotic
cells in vivo and, perhaps, a role in
preventing autoimmunity. The latter
seems possible given that the TIM
family is genetically associated with
autoimmune and allergic diseases.
However, ‘‘knockdown’’ or ‘‘knock-
out’’ of a widely expressed molecule
can be difficult to interpret, as we
have recently found, even with a line-
age-specific approach. Building on
our original in vitro studies pointing to
a phagocytic role for av integrins (Savill
et al., 1990), we used Cre-lox technol-
ogy to delete av in the myeloid line.
Such animals developed spontaneous
autoimmune ulcerative colitis and
presented evidence of deficient clear-
ance of apoptotic cells from the gut
by tolerogenic CD103+ dendritic cellsFigure 1. Newest Components in the ‘‘Phagocytic Synapse’’ Involved in the
Engulfment of Apoptotic Cells
Two different classes of transmembrane receptor, TIM-1 and TIM-4, and BAI1 are involved in in-
teracting directly with the anionic phospholipid PS that is exposed on cells undergoing apoptosis.
TIM-1 and TIM-4 are type I transmembrane proteins that present IgV domains, containing PS-
binding pockets, atop mucin ‘‘stalks.’’ BAI1 is a 7 transmembrane G protein-coupled receptor
with an extended extracellular region containing thrombospondin type I repeats (TSR) that mediate
PS binding. In both cases, these PS:PS-receptor interactions function not only to tether phagocytes
physically to apoptotic cells, but also to generate intracellular signals that mediate phagocytosis.
The intracytoplasmic tail of BAI1 forms a complex with the conserved ELMO-Dock180-Rac
phagocytic signaling module. Details of the intracellular signaling components of TIM-1 and
TIM-4 that regulate phagocytosis of apoptotic cells await elucidation; intriguingly, although
TIM-1 has tyrosine signaling motifs in its cytoplasmic domain, these are absent from TIM-4.(Lacy-Hulbert et al., 2007). However,
further studies will be required to de-
termine whether deficient clearance
of apoptotic cells is responsible for
the colitis phenotype or whether auto-
immunity in fact reflects defects in
another av function, activation of TGF-b.
Miyanishi et al. (2007) hint at similar
difficulties in interpretation of a TIM-4
deletion, because TIM family anti-
bodies have multiple effects on the
immune system.
Indeed, the recognition of apoptotic
cells by phagocytes is almost stagger-
ingly complex, involving various apo-
ptotic cell-surface molecules, a num-
ber of ‘‘bridging’’ molecules, and
multiple phagocytic receptors. Defi-
ciency of some but not all of these sys-
tems can result in autoimmunity, argu-
ing against ‘‘redundancy’’ as the only
explanation for this plethora of mecha-
nisms. Even recognition of apoptotic
cell-surface PS is likely to be complex.Immunity 27,Although the data sets are not com-
plete, both thrombospondin (TSP) and
GAS6 are likely to bridge apoptotic
cell PS to phagocyte av integrins and
Mer kinase, respectively. However,
deficiency of TSP is associated with
apparently nonautoimmune lung in-
flammation, whereas deficient Mer
function causes lupus-like systemic
autoimmunity (Savill et al., 2002). A
compelling body of evidence points
to milk fat globule epidermal growth
factor 8 (MFG-E8) as an ‘‘adaptor’’
bridging apoptotic cell PS to phago-
cyte av integrins and preventing auto-
immunity (Hanayama et al., 2004).
Lastly, potential complexity is further
emphasized by intriguing new data
from Park et al. (2007), which identify
a G protein-coupled receptor, BAI1,
capable of recognizing PS. BAI1
(which bears the rather confusing full
name of brain-specific angiogenesis
inhibitor-1, because an extracellularDecember 2007 ª2007 Elsevier Inc. 831
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vascularization) mediates recognition
and engulfment of apoptotic cells by
engaging the ELMO-Dock 180-Rac
signaling module. Thus, the concept
of a holy grail PS receptor may be
oversimplistic (Figure 1). Further com-
plexity is suggested by a potential role
for TIM family molecules in intercellular
communication mediated by PS-bear-
ing exosomes released from healthy
cells or plasma membrane blebs de-
rived from injured or dying cells. Miya-
nishi et al. (2007) demonstrate that
exogenous exosomes can direct asso-
ciation of TIM-4 and TIM-1 at the
plasma membrane.
Nevertheless, thanks to powerful
application of structural biology in-
sights to a classical cell-biology prob-
lem, we have convincing evidence that
phagocyte TIM-4 is a transmembrane
receptor for apoptotic cell-surfaceProtection One C
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Specific immunity is a layer of def
on challenge. In this issue of Imm
extreme by offering evidence tha
Breadth of recognition by cells of the
innate immune system is finite, but the
number of individual cells certainly
runsdeep.Bycontrast, lymphocytede-
velopment leavesuswitha tremendous
diversity of antigen receptors across
individual clones, enabling extreme
breadth of recognition. Experimental
estimates of the number of naive T cells
specific for any single antigen, how-
ever, remind us how truly thin adaptive
defense can be, with cell representa-
tion against single peptides on the
order of 101 or 102 (Moon et al., 2007).
Given the four-dimensional chal-
lenge of patrolling secondary lymphoid
832 Immunity 27, December 2007 ª2007PS. This finding will be an important
growth point for further study of the
mechanisms by which both the clear-
ance of apoptotic cells and the release
from cells of exosomes regulate im-
mune responses.
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how cell fate heterogeneity is gener-
ated during immunity, specifically in
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the activation of a single naive cell
yields a homogeneous or heteroge-
neous burst of fates (Reiner et al.,
2007). Activating signals to a naive
T cell elicit rapid changes in gene ex-
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1998). The signaling and transcrip-
tional circuitry that is mobilized by
activation results in the eventual re-
programming of the pattern of cellular
gene expression—converting the fate
of a cell to something other than naive.
